Jul. 28 at 8:42 PM
$TELO $1.18 to the downside A single drug capable of fixing the underlying genetic and cellular causes of cancer, rather than merely managing its symptoms or slowing its progression, holds an estimated global economic value of
$185 trillion. It represents the holy grail of medicine, shifting oncology from management to eradication.The potential value of such a therapy spans four critical dimensions: humanistic, clinical, economic, and market value -to the upside
